EODData

MEMBERSHIP REGISTER LOG IN

SHG, 603087: Gan & Lee Pharmaceuticals Co Ltd

09 Oct 2026
LAST:

75.52

CHANGE:
 1.96		OPEN:
73.56		HIGH:
76.40		ASK:
0.00		VOLUME:
10.7M
CHG(%):
2.66		PREV:
73.56		LOW:
72.31		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
09 Oct 2673.5676.4072.3175.5210.7M
08 Oct 2677.4078.2773.2073.5613.36M
30 Sep 2675.0379.2074.5677.4015.41M
29 Sep 2673.9775.6073.1074.859.15M
28 Sep 2673.4475.0073.4373.969.49M
24 Sep 2674.5075.9973.2973.4410.26M
23 Sep 2670.9774.6870.3174.5616.54M
22 Sep 2671.1971.6770.4570.696.84M

PROFILE

Name:Gan & Lee Pharmaceuticals Co Ltd
About:Gan & Lee Pharmaceuticals., a biopharmaceutical company, engages in the research, development, production, and sale of insulin analog active pharmaceutical ingredients (APIs) and injections in China. The company's products include Basalin, an insulin glargine injection; Prandilin, an insulin lispro and lispro mix 75/25 injection; Prandilin 25, an insulin lispro injection; Rapilin, an insulin aspart injection; Rapilin 30, an insulin aspart 30 injection; and Similin 30, an insulin injection. It also offers GanleePen, an insulin injection device; GanleeFine, an insulin pen needle; and medical devices. The company was formerly known as Beijing Gan & Lee Biotechnology Co., Ltd. and changed its name to Gan & Lee Pharmaceuticals. in April 2005. Gan & Lee Pharmaceuticals. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.
Sector:Healthcare
Industry:Medical Instruments & Supplies
Address:No. 8, Nanfeng West 1st Street, Beijing, China, 101109
Website:https://www.ganlee.com
ISIN:CNE100003ZH1

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:39.55 
Forward P/E:36.02 
PEG Ratio:36.02 
Price to Sales:10.36 
Price to Book:3.38 
Profit Margin:0.26 
Operating Margin:0.22 
Return on Assets:0.04 
Return on Equity:0.09 
Revenue:3.945B 
EBITDA:1.361B 
Shares:601.07M 
Market Cap:45.392B 

TECHNICAL INDICATORS

MA5:75.060.6%
MA10:73.432.8%
MA20:71.116.2%
MA50:70.487.1%
MA100:64.5017.1%
MA200:64.8116.5%
STO9:56.76
STO14:64.34
RSI14:71.23 
WPR14:-22.07
MTM14:6.32
ROC14:0.09 
ATR:2.79 
Week High:78.273.6%
Week Low:72.314.4%
Month High:79.204.9%
Month Low:65.5316.5%
Year High:79.995.9%
Year Low:51.5146.6%
Volatility:25.44 

RECENT SPLITS

Date Ratio
20 Aug 20201-1

RECENT DIVIDENDS

Date Amount
29 May 2026$1.00
11 Jun 2025$1.00
02 Dec 2024$0.50
18 Jun 2024$0.20
20 Jun 2022$0.30
21 May 2021$0.40